Free Trial

Universal Health Services (UHS) Financials

Universal Health Services logo
$173.77 +6.98 (+4.18%)
As of 03:59 PM Eastern
Annual Income Statements for Universal Health Services

Annual Income Statements for Universal Health Services

This table shows Universal Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
681 702 752 780 815 944 992 676 718 1,142
Consolidated Net Income / (Loss)
751 747 771 798 828 953 988 657 719 1,163
Net Income / (Loss) Continuing Operations
751 747 771 798 828 953 988 657 719 1,163
Total Pre-Tax Income
1,146 1,156 1,135 1,035 1,066 1,252 1,293 866 940 1,498
Total Operating Income
1,259 1,281 1,280 1,175 1,216 1,358 1,363 1,004 1,175 1,682
Total Gross Profit
4,831 5,181 5,429 5,518 5,789 5,946 6,478 6,637 7,174 8,309
Total Revenue
9,043 9,766 10,410 10,772 11,378 11,559 12,642 13,399 14,282 15,828
Operating Revenue
9,043 9,766 10,410 10,772 11,378 11,559 12,642 13,399 14,282 15,828
Total Cost of Revenue
4,212 4,586 4,981 5,255 5,589 5,613 6,164 6,762 7,107 7,519
Operating Cost of Revenue
4,212 4,586 4,981 5,255 5,589 5,613 6,164 6,762 7,107 7,519
Total Operating Expenses
3,572 3,899 4,149 4,342 4,573 4,587 5,115 5,634 5,999 6,627
Selling, General & Admin Expense
3,094 3,391 3,598 3,783 3,975 3,961 4,463 4,920 5,290 5,896
Depreciation Expense
399 417 448 453 490 510 533 582 568 585
Other Operating Expenses / (Income)
79 92 103 106 108 116 119 132 141 146
Total Other Income / (Expense), net
-113 -125 -145 -141 -150 -106 -70 -137 -235 -184
Interest Expense
113 125 145 155 163 106 84 127 207 186
Other Income / (Expense), net
- 0.00 0.00 14 13 0.01 14 -10 -28 2.23
Income Tax Expense
395 409 364 237 239 299 306 209 221 335
Net Income / (Loss) Attributable to Noncontrolling Interest
70 45 19 18 13 8.84 -3.96 -19 1.51 21
Basic Earnings per Share
$6.89 $7.22 $7.86 $8.35 $9.16 $11.06 $11.99 $9.23 $10.35 $17.16
Weighted Average Basic Shares Outstanding
98.80M 97.21M 95.65M 93.28M 88.76M 85.06M 82.52M 73.12M 69.32M 66.55M
Diluted Earnings per Share
$6.76 $7.14 $7.81 $8.31 $9.13 $10.99 $11.82 $9.14 $10.23 $16.82
Weighted Average Diluted Shares Outstanding
100.69M 98.38M 96.33M 93.75M 89.04M 85.59M 83.69M 73.83M 70.13M 67.90M
Weighted Average Basic & Diluted Shares Outstanding
98.80M 97.30M 95.70M 93.40M 86.73M 85.09M 74.81M 70.67M 67.22M 65.00M
Cash Dividends to Common per Share
- - - $0.40 $0.60 - $0.80 $0.80 $0.80 $0.80

Quarterly Income Statements for Universal Health Services

This table shows Universal Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
183 175 163 171 167 216 262 289 259 332
Consolidated Net Income / (Loss)
177 170 162 169 168 220 266 294 266 337
Net Income / (Loss) Continuing Operations
177 170 162 169 168 220 266 294 266 337
Total Pre-Tax Income
234 222 214 225 221 281 336 382 342 438
Total Operating Income
276 261 279 280 285 331 389 436 384 472
Total Gross Profit
1,659 1,746 1,714 1,778 1,778 1,905 2,001 2,051 2,051 2,206
Total Revenue
3,336 3,447 3,468 3,548 3,563 3,704 3,844 3,908 3,963 4,114
Operating Revenue
3,336 3,447 3,468 3,548 3,563 3,704 3,844 3,908 3,963 4,114
Total Cost of Revenue
1,677 1,701 1,753 1,770 1,785 1,799 1,843 1,856 1,912 1,907
Operating Cost of Revenue
1,677 1,701 1,753 1,770 1,785 1,799 1,843 1,856 1,912 1,907
Total Operating Expenses
1,383 1,485 1,435 1,498 1,493 1,573 1,612 1,615 1,667 1,734
Selling, General & Admin Expense
1,204 1,302 1,259 1,319 1,320 1,393 1,436 1,431 1,480 1,549
Depreciation Expense
146 148 142 144 137 145 141 147 150 147
Other Operating Expenses / (Income)
33 35 35 35 35 35 35 36 37 38
Total Other Income / (Expense), net
-42 -39 -65 -55 -65 -50 -53 -54 -43 -34
Interest Expense
36 44 51 49 53 54 53 49 45 40
Other Income / (Expense), net
-6.02 4.84 -14 -6.60 -11 3.52 0.15 -5.49 2.03 5.55
Income Tax Expense
57 52 52 55 52 62 70 88 76 101
Net Income / (Loss) Attributable to Noncontrolling Interest
-6.00 -4.45 -0.74 -2.01 1.02 3.24 3.99 5.18 7.20 4.65
Basic Earnings per Share
$2.52 $2.44 $2.31 $2.44 $2.42 $3.18 $3.90 $4.32 $3.89 $5.05
Weighted Average Basic Shares Outstanding
72.60M 73.12M 70.54M 70.07M 68.87M 69.32M 67.20M 66.88M 66.54M 66.55M
Diluted Earnings per Share
$2.50 $2.42 $2.28 $2.42 $2.40 $3.13 $3.82 $4.26 $3.80 $4.94
Weighted Average Diluted Shares Outstanding
73.06M 73.83M 71.49M 70.84M 69.62M 70.13M 68.48M 67.92M 68.11M 67.90M
Weighted Average Basic & Diluted Shares Outstanding
71.41M 70.67M 70.18M 69.39M 68.26M 67.22M 66.93M 66.71M 65.97M 65.00M

Annual Cash Flow Statements for Universal Health Services

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
29 4.67 45 32 -94 1,173 -1,100 22 14 10
Net Cash From Operating Activities
1,068 1,334 1,248 1,275 1,438 2,360 884 996 1,268 2,067
Net Cash From Continuing Operating Activities
1,068 1,334 1,248 1,275 1,438 2,360 884 996 1,268 2,067
Net Income / (Loss) Continuing Operations
751 747 771 798 828 953 988 657 719 1,163
Consolidated Net Income / (Loss)
751 747 771 798 828 953 988 657 719 1,163
Depreciation Expense
399 417 448 453 490 510 533 582 568 585
Non-Cash Adjustments To Reconcile Net Income
84 93 57 116 160 69 100 144 81 93
Changes in Operating Assets and Liabilities, net
-165 77 -28 -92 -39 828 -737 -386 -101 227
Net Cash From Investing Activities
-913 -1,155 -685 -747 -688 -803 -914 -647 -763 -911
Net Cash From Continuing Investing Activities
-913 -1,155 -685 -747 -688 -803 -914 -647 -763 -911
Purchase of Property, Plant & Equipment
-379 -541 -558 -665 -634 -731 -856 -734 -743 -944
Acquisitions
-534 -614 -23 -110 -8.01 -52 -105 -20 -3.73 -19
Purchase of Investments
- - -72 -15 -34 -24 1.36 95 -41 13
Divestitures
3.39 0.00 0.11 14 9.45 8.17 25 12 24 39
Other Investing Activities, net
-3.30 0.00 -32 -36 -21 -3.00 20 0.10 0.02 0.28
Net Cash From Financing Activities
-125 -171 -519 -492 -845 -385 -1,069 -318 -494 -1,145
Net Cash From Continuing Financing Activities
-125 -171 -519 -492 -845 -385 -1,069 -318 -494 -1,145
Repayment of Debt
-69 -472 -143 -844 -57 -973 -3,057 -93 -86 -2,653
Repurchase of Common Equity
-210 -353 -364 -397 -771 -207 -1,221 -833 -547 -671
Payment of Dividends
-102 -108 -63 -52 -69 -19 -60 -112 -60 -47
Issuance of Debt
234 1,171 41 791 39 802 3,255 705 185 2,210
Issuance of Common Equity
8.44 9.50 10 10 12 12 13 14 14 15
Effect of Exchange Rate Changes
-1.61 - - -2.91 - 0.74 -0.50 -8.42 3.06 -0.83
Cash Interest Paid
107 107 136 150 157 113 76 120 200 168
Cash Income Taxes Paid
381 345 371 294 261 286 363 251 258 325

Quarterly Cash Flow Statements for Universal Health Services

This table details how cash moves in and out of Universal Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-37 35 8.20 -30 1.33 34 -7.67 17 -19 20
Net Cash From Operating Activities
221 297 291 363 162 452 396 679 333 658
Net Cash From Continuing Operating Activities
221 297 291 363 162 452 396 679 333 658
Net Income / (Loss) Continuing Operations
177 170 162 169 168 220 266 294 266 337
Consolidated Net Income / (Loss)
177 170 162 169 168 220 266 294 266 337
Depreciation Expense
146 148 142 144 137 145 141 147 150 147
Non-Cash Adjustments To Reconcile Net Income
21 80 21 16 23 22 16 27 28 22
Changes in Operating Assets and Liabilities, net
-123 -102 -34 34 -166 65 -26 211 -111 153
Net Cash From Investing Activities
-73 -248 -178 -170 -176 -239 -195 -243 -266 -208
Net Cash From Continuing Investing Activities
-73 -248 -178 -170 -176 -239 -195 -243 -266 -208
Purchase of Property, Plant & Equipment
-162 -164 -169 -168 -200 -206 -209 -241 -248 -246
Acquisitions
-6.18 -1.64 0.00 -3.73 - - 0.00 - - -19
Purchase of Investments
93 -82 -19 -12 24 -33 8.32 -1.49 -42 49
Divestitures
1.77 - 9.26 14 - 0.50 5.43 - 25 8.34
Other Investing Activities, net
- - 0.00 - - 0.02 0.16 0.04 0.00 0.08
Net Cash From Financing Activities
-179 -15 -106 -224 18 -182 -209 -420 -90 -427
Net Cash From Continuing Financing Activities
-179 -15 -106 -224 18 -182 -209 -420 -90 -427
Repayment of Debt
33 104 -17 -77 40 -31 -64 -319 -2,099 -171
Repurchase of Common Equity
-158 -110 -85 -125 -176 -162 -142 -96 -183 -250
Payment of Dividends
-62 -14 -18 -14 -14 -13 -18 -8.83 -10 -9.74
Issuance of Common Equity
3.74 3.67 2.99 3.61 3.24 3.81 3.24 3.99 3.64 4.21
Effect of Exchange Rate Changes
- - - - -1.88 2.56 - - 3.09 -3.53
Cash Interest Paid
35 41 50 47 52 51 48 48 48 24
Cash Income Taxes Paid
37 69 2.36 131 57 67 2.67 129 105 88

Annual Balance Sheets for Universal Health Services

This table presents Universal Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
9,615 10,318 10,762 11,265 11,668 13,477 13,094 13,494 13,968 14,470
Total Current Assets
1,718 1,681 1,798 1,938 1,916 3,282 2,264 2,537 2,811 2,816
Cash & Equivalents
61 34 74 105 61 1,224 115 103 119 126
Accounts Receivable
1,302 1,440 1,501 1,510 1,561 1,729 1,747 2,018 2,238 2,178
Inventories, net
116 125 136 148 160 190 207 219 217 221
Other Current Assets
103 83 87 174 134 138 195 198 237 292
Plant, Property, & Equipment, net
3,836 4,331 4,572 4,848 5,017 5,373 5,874 5,918 6,125 6,572
Plant, Property & Equipment, gross
6,531 7,314 7,921 8,519 9,106 9,886 10,771 11,086 11,777 12,643
Accumulated Depreciation
2,695 2,983 3,349 3,716 4,090 4,513 4,896 5,167 5,653 6,071
Total Noncurrent Assets
11,766 4,305 4,392 4,474 4,736 4,822 4,956 5,038 5,032 5,081
Goodwill
3,596 3,784 3,825 3,845 3,870 3,883 3,963 3,909 3,932 3,933
Noncurrent Deferred & Refundable Income Taxes
0.00 1.23 3.01 - 16 23 46 68 86 118
Other Noncurrent Operating Assets
8,170 520 564 630 850 916 947 1,061 580 1,030
Total Liabilities & Shareholders' Equity
9,615 10,318 10,762 11,265 11,668 13,477 13,094 13,494 13,968 14,470
Total Liabilities
5,064 5,711 5,704 5,795 6,085 7,070 6,895 7,524 7,766 7,707
Total Current Liabilities
1,100 1,317 1,848 1,449 1,563 2,481 1,984 1,914 2,013 2,210
Short-Term Debt
63 106 546 63 88 332 48 81 127 40
Accounts Payable
366 440 442 446 447 571 659 637 614 632
Accrued Expenses
349 403 389 389 354 526 560 524 473 635
Current Deferred Revenue
- - - - 0.00 376 0.01 2.40 5.38 0.00
Current Deferred & Payable Income Tax Liabilities
3.99 2.15 18 2.43 2.52 44 11 4.61 2.05 14
Current Employee Benefit Liabilities
245 275 305 343 380 410 466 471 549 623
Other Taxes Payable
60 68 86 56 72 152 161 111 154 162
Other Current Liabilities
- - 39 129 201 60 64 68 72 75
Other Current Nonoperating Liabilities
13 23 24 19 19 9.46 14 16 17 30
Total Noncurrent Liabilities
3,963 4,394 3,856 4,347 4,522 4,589 4,911 5,610 5,752 5,497
Long-Term Debt
3,369 4,030 3,494 3,935 3,897 3,524 4,142 4,727 4,786 4,464
Capital Lease Obligations
- - - - 270 601 - 396 - 376
Other Noncurrent Operating Liabilities
279 275 306 362 330 459 769 488 967 656
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
243 9.32 6.70 4.29 4.33 4.57 5.12 4.70 5.19 13
Total Equity & Noncontrolling Interests
4,309 4,598 5,051 5,466 5,579 6,402 6,193 5,965 6,197 6,750
Total Preferred & Common Equity
4,250 4,533 4,990 5,389 5,503 6,317 6,090 5,921 6,149 6,666
Total Common Equity
4,250 4,533 4,990 5,389 5,503 6,317 6,090 5,921 6,149 6,666
Common Stock
0.98 0.97 0.94 0.91 0.00 0.85 0.77 0.71 0.67 0.65
Retained Earnings
4,272 4,558 4,981 5,384 5,471 6,268 6,604 5,930 6,139 6,658
Accumulated Other Comprehensive Income / (Loss)
-23 -25 7.18 4.24 32 48 30 -9.67 9.29 7.20
Noncontrolling Interest
60 64 62 77 75 85 103 45 48 83

Quarterly Balance Sheets for Universal Health Services

This table presents Universal Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Total Assets
13,379 13,494 13,556 13,732 13,873 13,968 14,046 14,071 14,354 14,470
Total Current Assets
2,457 2,537 2,559 2,625 2,753 2,811 2,871 2,741 2,802 2,816
Cash & Equivalents
75 103 110 79 81 119 112 129 106 126
Accounts Receivable
1,902 2,018 2,032 2,103 2,234 2,238 2,299 2,157 2,214 2,178
Inventories, net
218 219 216 215 215 217 216 219 220 221
Other Current Assets
262 198 201 226 223 237 243 236 262 292
Plant, Property, & Equipment, net
5,936 5,918 5,954 6,028 6,087 6,125 6,185 6,335 6,443 6,572
Plant, Property & Equipment, gross
11,104 11,086 11,251 11,442 11,610 11,777 11,955 12,240 12,448 12,643
Accumulated Depreciation
5,167 5,167 5,297 5,414 5,523 5,653 5,770 5,905 6,006 6,071
Total Noncurrent Assets
4,986 5,038 5,043 5,080 5,033 5,032 4,990 4,996 5,109 5,081
Goodwill
3,874 3,909 3,914 3,930 3,912 3,932 3,928 3,942 3,965 3,933
Noncurrent Deferred & Refundable Income Taxes
56 68 91 110 100 86 95 108 122 118
Other Noncurrent Operating Assets
1,056 1,061 1,038 1,040 1,022 580 967 946 1,022 1,030
Total Liabilities & Shareholders' Equity
13,379 13,494 13,556 13,732 13,873 13,968 14,046 14,071 14,354 14,470
Total Liabilities
7,470 7,524 7,499 7,599 7,762 7,766 7,735 7,515 7,667 7,707
Total Current Liabilities
1,939 1,914 1,863 2,035 1,990 2,013 2,075 2,149 2,011 2,210
Short-Term Debt
66 81 96 111 127 127 127 128 38 40
Accounts Payable
1,795 637 1,636 1,843 1,783 614 1,830 1,926 1,896 632
Accrued Expenses
- 524 - - - 473 - - - 635
Current Deferred Revenue
- 2.40 - - - 5.38 - - - 0.00
Current Deferred & Payable Income Tax Liabilities
7.74 4.61 58 6.96 7.15 2.05 47 23 3.80 14
Current Employee Benefit Liabilities
- 471 - - - 549 - - - 623
Other Taxes Payable
- 111 - - - 154 - - - 162
Other Current Liabilities
70 68 73 74 73 72 71 72 73 75
Other Current Nonoperating Liabilities
- 16 - - - 17 - - - 30
Total Noncurrent Liabilities
5,531 5,610 5,636 5,564 5,772 5,752 5,660 5,366 5,656 5,497
Long-Term Debt
4,638 4,727 4,707 4,605 4,796 4,786 4,734 4,417 4,618 4,464
Capital Lease Obligations
393 396 396 388 389 - 374 380 378 376
Other Noncurrent Operating Liabilities
500 488 532 571 588 967 551 570 660 656
Commitments & Contingencies
- 0.00 - - - 0.00 - - - 0.00
Redeemable Noncontrolling Interest
4.56 4.70 4.27 4.21 4.72 5.19 4.99 5.42 5.62 13
Total Equity & Noncontrolling Interests
5,904 5,965 6,052 6,129 6,106 6,197 6,306 6,551 6,681 6,750
Total Preferred & Common Equity
5,855 5,921 0.00 6,087 6,065 6,149 6,257 6,485 6,606 6,666
Total Common Equity
5,855 5,921 0.00 6,087 6,065 6,149 6,257 6,485 6,606 6,666
Common Stock
5,855 0.71 - 6,087 6,065 0.67 6,257 6,485 6,606 0.65
Retained Earnings
- 5,930 - - - 6,139 - - - 6,658
Accumulated Other Comprehensive Income / (Loss)
- -9.67 - - - 9.29 - - - 7.20
Noncontrolling Interest
49 45 6,052 42 42 48 49 65 75 83

Annual Metrics and Ratios for Universal Health Services

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
10.22% 7.99% 6.59% 3.48% 5.63% 1.59% 9.37% 5.99% 6.59% 10.82%
EBITDA Growth
15.23% 2.41% 1.77% -4.95% 4.68% 8.69% 2.21% -17.55% 8.90% 32.29%
EBIT Growth
18.44% 1.75% -0.10% -7.08% 3.33% 10.52% 1.37% -27.88% 15.50% 46.81%
NOPAT Growth
19.23% 0.35% 5.07% 4.19% 4.10% 9.54% 0.70% -26.88% 18.12% 45.26%
Net Income Growth
24.08% -0.47% 3.23% 3.44% 3.72% 15.13% 3.66% -33.48% 9.49% 61.70%
EPS Growth
24.72% 5.62% 9.38% 6.40% 9.87% 20.37% 7.55% -22.67% 11.93% 64.42%
Operating Cash Flow Growth
3.13% 24.86% -6.47% 2.18% 12.84% 64.08% -62.56% 12.71% 27.29% 63.05%
Free Cash Flow Firm Growth
1.34% 2,652.50% -92.83% 3.89% -8.83% 124.67% -65.95% -109.53% 2,642.29% -20.87%
Invested Capital Growth
7.77% -44.17% 3.61% 3.65% 4.46% -1.50% 6.62% 7.77% -0.67% 4.86%
Revenue Q/Q Growth
-0.17% 3.34% 1.63% 1.05% 1.26% 1.68% 1.51% 1.30% 1.83% 2.66%
EBITDA Q/Q Growth
0.26% -0.18% 1.82% -3.55% 7.68% 3.79% -4.83% -2.76% 3.98% 6.81%
EBIT Q/Q Growth
-0.04% -0.59% 1.95% -5.16% 10.12% 4.78% -6.54% -5.67% 6.35% 9.30%
NOPAT Q/Q Growth
-0.11% -1.23% 6.49% -5.04% 6.60% 5.43% -6.92% -4.89% 6.99% 8.69%
Net Income Q/Q Growth
0.11% -1.66% 6.39% -7.15% 11.36% 6.69% -6.95% -8.82% 7.35% 11.23%
EPS Q/Q Growth
0.60% 0.42% 7.28% -6.63% 13.42% 7.64% -4.68% -5.97% 7.46% 12.06%
Operating Cash Flow Q/Q Growth
-6.52% -5.29% 15.94% -3.30% 0.56% -7.50% 25.58% -2.42% 13.94% 11.07%
Free Cash Flow Firm Q/Q Growth
-148.06% 2,542.46% 1,204.47% 20.49% -18.10% -34.07% 15,366.04% 80.25% 126.45% -17.02%
Invested Capital Q/Q Growth
108.56% 8.55% 1.52% -0.11% 1.70% 9.38% 3.53% 1.42% -2.90% -0.58%
Profitability Metrics
- - - - - - - - - -
Gross Margin
53.42% 53.05% 52.15% 51.22% 50.88% 51.44% 51.24% 49.53% 50.23% 52.50%
EBITDA Margin
18.33% 17.39% 16.60% 15.25% 15.11% 16.17% 15.11% 11.75% 12.01% 14.33%
Operating Margin
13.93% 13.12% 12.30% 10.91% 10.69% 11.75% 10.78% 7.49% 8.23% 10.63%
EBIT Margin
13.93% 13.12% 12.30% 11.04% 10.80% 11.75% 10.89% 7.41% 8.03% 10.64%
Profit (Net Income) Margin
8.30% 7.65% 7.41% 7.41% 7.27% 8.24% 7.81% 4.90% 5.04% 7.35%
Tax Burden Percent
65.51% 64.61% 67.96% 77.13% 77.61% 76.10% 76.36% 75.84% 76.49% 77.65%
Interest Burden Percent
90.99% 90.24% 88.66% 86.97% 86.76% 92.18% 93.92% 87.22% 81.98% 88.95%
Effective Tax Rate
34.49% 35.39% 32.04% 22.87% 22.39% 23.90% 23.64% 24.16% 23.51% 22.35%
Return on Invested Capital (ROIC)
5.47% 6.79% 9.79% 9.84% 9.84% 10.63% 10.44% 7.12% 8.14% 11.58%
ROIC Less NNEP Spread (ROIC-NNEP)
4.78% 5.73% 7.35% 7.09% 6.98% 8.46% 8.99% 4.86% 4.52% 8.60%
Return on Net Nonoperating Assets (RNNOA)
12.02% 9.52% 6.17% 5.32% 5.13% 5.26% 5.23% 3.68% 3.68% 6.37%
Return on Equity (ROE)
17.49% 16.32% 15.96% 15.16% 14.97% 15.89% 15.67% 10.80% 11.82% 17.94%
Cash Return on Invested Capital (CROIC)
-2.01% 63.48% 6.24% 6.26% 5.48% 12.14% 4.03% -0.36% 8.81% 6.83%
Operating Return on Assets (OROA)
13.55% 12.86% 12.15% 10.80% 10.72% 10.80% 10.36% 7.47% 8.35% 11.84%
Return on Assets (ROA)
8.08% 7.50% 7.32% 7.24% 7.22% 7.58% 7.43% 4.94% 5.24% 8.18%
Return on Common Equity (ROCE)
16.28% 15.65% 15.73% 14.94% 14.76% 15.67% 15.42% 10.66% 11.72% 17.74%
Return on Equity Simple (ROE_SIMPLE)
17.66% 16.48% 15.46% 14.81% 15.04% 15.08% 16.22% 11.10% 11.70% 17.45%
Net Operating Profit after Tax (NOPAT)
825 828 870 906 944 1,034 1,041 761 899 1,306
NOPAT Margin
9.12% 8.48% 8.36% 8.41% 8.29% 8.94% 8.23% 5.68% 6.29% 8.25%
Net Nonoperating Expense Percent (NNEP)
0.69% 1.06% 2.43% 2.75% 2.86% 2.17% 1.45% 2.26% 3.62% 2.98%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 6.81% 8.09% 11.23%
Cost of Revenue to Revenue
46.58% 46.95% 47.85% 48.78% 49.12% 48.56% 48.76% 50.47% 49.77% 47.50%
SG&A Expenses to Revenue
34.21% 34.72% 34.56% 35.12% 34.94% 34.27% 35.30% 36.72% 37.04% 37.25%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
39.49% 39.93% 39.86% 40.31% 40.19% 39.69% 40.46% 42.04% 42.00% 41.87%
Earnings before Interest and Taxes (EBIT)
1,259 1,281 1,280 1,189 1,229 1,358 1,377 993 1,147 1,684
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,658 1,698 1,728 1,643 1,719 1,869 1,910 1,575 1,715 2,269
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
2.67 2.20 2.09 1.95 2.23 1.81 1.69 1.68 1.69 1.78
Price to Tangible Book Value (P/TBV)
17.36 13.32 8.97 6.80 7.53 4.70 4.83 4.95 4.68 4.33
Price to Revenue (P/Rev)
1.25 1.02 1.00 0.98 1.08 0.99 0.81 0.74 0.73 0.75
Price to Earnings (P/E)
16.67 14.21 13.88 13.47 15.09 12.13 10.36 14.74 14.44 10.36
Dividend Yield
0.35% 0.39% 0.36% 0.35% 0.43% 0.52% 0.63% 0.57% 0.53% 0.45%
Earnings Yield
6.00% 7.04% 7.20% 7.42% 6.63% 8.24% 9.66% 6.78% 6.93% 9.65%
Enterprise Value to Invested Capital (EV/IC)
0.96 1.62 1.60 1.54 1.69 1.53 1.40 1.36 1.38 1.45
Enterprise Value to Revenue (EV/Rev)
1.66 1.45 1.39 1.34 1.46 1.28 1.14 1.13 1.06 1.05
Enterprise Value to EBITDA (EV/EBITDA)
9.06 8.34 8.38 8.81 9.63 7.90 7.57 9.59 8.87 7.35
Enterprise Value to EBIT (EV/EBIT)
11.93 11.05 11.31 12.17 13.48 10.87 10.50 15.22 13.26 9.91
Enterprise Value to NOPAT (EV/NOPAT)
18.20 17.10 16.64 15.97 17.55 14.29 13.89 19.85 16.92 12.78
Enterprise Value to Operating Cash Flow (EV/OCF)
14.06 10.61 11.61 11.36 11.52 6.26 16.36 15.17 12.00 8.07
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 1.83 26.10 25.12 31.52 12.51 35.95 0.00 15.62 21.66
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.75 0.90 0.80 0.73 0.76 0.70 0.68 0.87 0.79 0.72
Long-Term Debt to Equity
0.74 0.87 0.69 0.72 0.75 0.64 0.67 0.86 0.77 0.72
Financial Leverage
2.51 1.66 0.84 0.75 0.73 0.62 0.58 0.76 0.82 0.74
Leverage Ratio
2.17 2.18 2.18 2.09 2.07 2.10 2.11 2.19 2.26 2.19
Compound Leverage Factor
1.97 1.96 1.93 1.82 1.80 1.93 1.98 1.91 1.85 1.95
Debt to Total Capital
42.98% 47.31% 44.40% 42.23% 43.25% 41.03% 40.34% 46.57% 44.20% 41.92%
Short-Term Debt to Total Capital
0.79% 1.21% 6.00% 0.67% 0.89% 3.06% 0.47% 0.73% 1.14% 0.34%
Long-Term Debt to Total Capital
42.20% 46.10% 38.41% 41.56% 42.36% 37.97% 39.87% 45.84% 43.06% 41.57%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.78% 0.84% 0.75% 0.85% 0.80% 0.82% 1.04% 0.44% 0.48% 0.83%
Common Equity to Total Capital
53.23% 51.85% 54.84% 56.92% 55.94% 58.15% 58.62% 52.99% 55.32% 57.25%
Debt to EBITDA
2.07 2.44 2.34 2.43 2.47 2.39 2.19 3.30 2.86 2.15
Net Debt to EBITDA
2.03 2.42 2.29 2.37 2.44 1.73 2.13 3.24 2.79 2.10
Long-Term Debt to EBITDA
2.03 2.37 2.02 2.40 2.42 2.21 2.17 3.25 2.79 2.13
Debt to NOPAT
4.16 5.00 4.64 4.41 4.51 4.31 4.03 6.84 5.46 3.74
Net Debt to NOPAT
4.08 4.95 4.56 4.30 4.44 3.13 3.91 6.70 5.33 3.64
Long-Term Debt to NOPAT
4.08 4.87 4.02 4.34 4.42 3.99 3.98 6.73 5.32 3.71
Altman Z-Score
3.42 3.07 3.10 3.11 3.23 2.88 2.94 2.70 2.78 3.09
Noncontrolling Interest Sharing Ratio
6.95% 4.10% 1.47% 1.42% 1.45% 1.41% 1.57% 1.30% 0.84% 1.15%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.56 1.28 0.97 1.34 1.23 1.32 1.14 1.33 1.40 1.27
Quick Ratio
1.24 1.12 0.85 1.11 1.04 1.19 0.94 1.11 1.17 1.04
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-303 7,736 555 576 525 1,181 402 -38 974 770
Operating Cash Flow to CapEx
281.62% 246.36% 223.78% 191.70% 226.85% 322.73% 103.28% 135.70% 170.62% 219.02%
Free Cash Flow to Firm to Interest Expense
-2.67 61.86 3.82 3.72 3.23 11.11 4.80 -0.30 4.71 4.14
Operating Cash Flow to Interest Expense
9.41 10.67 8.59 8.23 8.84 22.21 10.56 7.85 6.13 11.11
Operating Cash Flow Less CapEx to Interest Expense
6.07 6.34 4.75 3.94 4.94 15.33 0.34 2.07 2.54 6.04
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.97 0.98 0.99 0.98 0.99 0.92 0.95 1.01 1.04 1.11
Accounts Receivable Turnover
7.00 7.12 7.08 7.16 7.41 7.03 7.27 7.12 6.71 7.17
Inventory Turnover
37.59 37.99 38.09 36.95 36.28 32.05 31.03 31.80 32.64 34.34
Fixed Asset Turnover
2.41 2.39 2.34 2.29 2.31 2.23 2.25 2.27 2.37 2.49
Accounts Payable Turnover
11.99 11.38 11.30 11.84 12.52 11.03 10.03 10.44 11.37 12.07
Days Sales Outstanding (DSO)
52.17 51.24 51.55 51.01 49.25 51.94 50.17 51.27 54.38 50.92
Days Inventory Outstanding (DIO)
9.71 9.61 9.58 9.88 10.06 11.39 11.76 11.48 11.18 10.63
Days Payable Outstanding (DPO)
30.44 32.07 32.31 30.83 29.15 33.08 36.40 34.96 32.11 30.24
Cash Conversion Cycle (CCC)
31.44 28.77 28.83 30.06 30.17 30.25 25.53 27.79 33.46 31.30
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
15,640 8,732 9,047 9,377 9,796 9,649 10,288 11,087 11,012 11,548
Invested Capital Turnover
0.60 0.80 1.17 1.17 1.19 1.19 1.27 1.25 1.29 1.40
Increase / (Decrease) in Invested Capital
1,128 -6,908 315 330 418 -147 639 799 -75 535
Enterprise Value (EV)
15,019 14,154 14,480 14,477 16,564 14,772 14,453 15,111 15,208 16,687
Market Capitalization
11,347 9,978 10,445 10,503 12,292 11,449 10,270 9,961 10,362 11,836
Book Value per Share
$43.16 $46.76 $52.57 $58.25 $62.84 $74.34 $75.76 $82.91 $90.08 $101.06
Tangible Book Value per Share
$6.64 $7.73 $12.27 $16.70 $18.65 $28.65 $26.46 $28.16 $32.47 $41.44
Total Capital
7,983 8,743 9,098 9,469 9,837 10,864 10,388 11,174 11,114 11,644
Total Debt
3,431 4,136 4,040 3,999 4,254 4,457 4,190 5,204 4,912 4,881
Total Long-Term Debt
3,369 4,030 3,494 3,935 4,167 4,125 4,142 5,122 4,786 4,841
Net Debt
3,370 4,102 3,966 3,893 4,193 3,233 4,075 5,101 4,793 4,755
Capital Expenditures (CapEx)
379 541 558 665 634 731 856 734 743 944
Debt-free, Cash-free Net Working Capital (DFCFNWC)
619 436 421 447 379 -92 213 602 805 520
Debt-free Net Working Capital (DFNWC)
681 470 496 553 440 1,133 328 704 925 646
Net Working Capital (NWC)
618 364 -50 489 353 801 279 623 798 606
Net Nonoperating Expense (NNE)
74 81 99 109 116 81 53 104 180 143
Net Nonoperating Obligations (NNO)
11,088 4,125 3,989 3,907 4,212 3,242 4,089 5,117 4,810 4,785
Total Depreciation and Amortization (D&A)
399 417 448 453 490 510 533 582 568 585
Debt-free, Cash-free Net Working Capital to Revenue
6.85% 4.47% 4.05% 4.15% 3.33% -0.79% 1.68% 4.49% 5.64% 3.29%
Debt-free Net Working Capital to Revenue
7.53% 4.81% 4.76% 5.13% 3.87% 9.80% 2.59% 5.26% 6.47% 4.08%
Net Working Capital to Revenue
6.83% 3.73% -0.48% 4.54% 3.10% 6.93% 2.21% 4.65% 5.59% 3.83%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$6.89 $7.22 $7.86 $8.35 $9.16 $11.06 $11.99 $9.23 $10.35 $17.16
Adjusted Weighted Average Basic Shares Outstanding
98.80M 97.21M 95.65M 93.28M 88.76M 85.06M 82.52M 73.12M 69.32M 66.55M
Adjusted Diluted Earnings per Share
$6.76 $7.14 $7.81 $8.31 $9.13 $10.99 $11.82 $9.14 $10.23 $16.82
Adjusted Weighted Average Diluted Shares Outstanding
100.69M 98.38M 96.33M 93.75M 89.04M 85.59M 83.69M 73.83M 70.13M 67.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
97.67M 96.60M 94.27M 90.78M 86.73M 85.09M 74.81M 70.67M 67.22M 65.00M
Normalized Net Operating Profit after Tax (NOPAT)
825 828 870 906 944 1,034 1,041 761 899 1,306
Normalized NOPAT Margin
9.12% 8.48% 8.36% 8.41% 8.29% 8.94% 8.23% 5.68% 6.29% 8.25%
Pre Tax Income Margin
12.67% 11.84% 10.90% 9.60% 9.37% 10.83% 10.23% 6.46% 6.58% 9.46%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
11.10 10.25 8.82 7.68 7.55 12.78 16.46 7.83 5.55 9.05
NOPAT to Interest Expense
7.27 6.62 5.99 5.85 5.80 9.73 12.44 6.00 4.35 7.02
EBIT Less CapEx to Interest Expense
7.75 5.92 4.98 3.39 3.66 5.90 6.23 2.04 1.96 3.98
NOPAT Less CapEx to Interest Expense
3.93 2.29 2.15 1.56 1.90 2.84 2.21 0.21 0.75 1.95
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
13.55% 14.52% 8.16% 6.51% 8.32% 2.01% 6.05% 17.10% 8.28% 4.03%
Augmented Payout Ratio
41.50% 61.81% 55.40% 56.32% 101.43% 23.71% 129.67% 143.88% 84.37% 61.70%

Quarterly Metrics and Ratios for Universal Health Services

This table displays calculated financial ratios and metrics derived from Universal Health Services' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
5.70% 5.24% 5.30% 6.76% 6.80% 7.44% 10.85% 10.13% 11.23% 11.08%
EBITDA Growth
-6.06% -9.74% 11.26% 10.02% -1.12% 15.83% 30.33% 38.61% 30.33% 30.12%
EBIT Growth
-12.41% -18.33% 19.54% 16.19% 1.49% 25.73% 46.77% 57.54% 41.01% 42.82%
NOPAT Growth
-13.48% -16.26% 20.20% 19.43% 4.39% 29.18% 45.47% 59.30% 37.57% 40.42%
Net Income Growth
-19.40% -27.17% 7.52% 6.63% -4.98% 28.91% 63.71% 73.85% 58.27% 53.47%
EPS Growth
-3.85% -19.33% 12.87% 10.00% -4.00% 29.34% 67.54% 76.03% 58.33% 57.83%
Operating Cash Flow Growth
-50.10% -7.68% -34.73% 1,012.86% -26.74% 52.18% 36.34% 87.16% 105.97% 45.53%
Free Cash Flow Firm Growth
10.19% -49.88% 43.75% 65.40% 75.46% 155.64% 104.11% 169.49% 113.49% -151.65%
Invested Capital Growth
10.00% 7.77% 6.51% 3.88% 3.75% -0.67% 2.59% 1.74% 2.41% 4.86%
Revenue Q/Q Growth
0.38% 3.33% 0.60% 2.33% 0.41% 3.95% 3.78% 1.67% 1.42% 3.80%
EBITDA Q/Q Growth
9.62% -0.28% -1.92% 2.62% -1.48% 16.81% 10.35% 9.15% -7.37% 16.62%
EBIT Q/Q Growth
14.64% -1.35% -0.47% 3.23% 0.13% 22.21% 16.19% 10.80% -10.38% 23.78%
NOPAT Q/Q Growth
17.85% -3.83% 5.53% -0.14% 3.01% 19.01% 18.84% 9.35% -11.04% 21.47%
Net Income Q/Q Growth
11.36% -3.64% -4.69% 4.27% -0.76% 30.72% 21.04% 10.72% -9.66% 26.75%
EPS Q/Q Growth
13.64% -3.20% -5.79% 6.14% -0.83% 30.42% 22.04% 11.52% -10.80% 30.00%
Operating Cash Flow Q/Q Growth
576.62% 34.73% -2.20% 24.83% -55.46% 179.86% -12.38% 71.36% -50.98% 97.74%
Free Cash Flow Firm Q/Q Growth
-32.46% 23.76% 21.60% 56.29% 6.04% 272.82% 160.80% 638.20% -81.75% -761.44%
Invested Capital Q/Q Growth
1.77% 1.42% 0.54% 0.10% 1.65% -2.90% 0.50% -0.73% 2.32% -0.58%
Profitability Metrics
- - - - - - - - - -
Gross Margin
49.72% 50.65% 49.44% 50.11% 49.90% 51.42% 52.06% 52.49% 51.75% 53.63%
EBITDA Margin
12.46% 12.03% 11.73% 11.76% 11.54% 12.97% 13.79% 14.80% 13.52% 15.19%
Operating Margin
8.27% 7.58% 8.04% 7.90% 8.01% 8.94% 10.11% 11.17% 9.69% 11.49%
EBIT Margin
8.09% 7.72% 7.64% 7.71% 7.69% 9.04% 10.12% 11.03% 9.74% 11.62%
Profit (Net Income) Margin
5.30% 4.94% 4.68% 4.77% 4.72% 5.93% 6.92% 7.53% 6.71% 8.19%
Tax Burden Percent
75.49% 76.63% 75.84% 75.35% 76.19% 78.12% 79.09% 77.05% 77.86% 76.90%
Interest Burden Percent
86.79% 83.51% 80.80% 82.15% 80.51% 83.99% 86.42% 88.65% 88.44% 91.69%
Effective Tax Rate
24.51% 23.37% 24.16% 24.65% 23.81% 21.88% 20.91% 22.95% 22.14% 23.10%
Return on Invested Capital (ROIC)
7.91% 7.29% 7.66% 7.50% 7.69% 9.03% 10.39% 11.48% 10.14% 12.39%
ROIC Less NNEP Spread (ROIC-NNEP)
7.18% 6.64% 6.64% 6.65% 6.72% 8.24% 9.57% 10.63% 9.48% 11.85%
Return on Net Nonoperating Assets (RNNOA)
5.02% 5.02% 5.29% 5.44% 5.73% 6.72% 7.90% 8.22% 7.53% 8.77%
Return on Equity (ROE)
12.94% 12.31% 12.95% 12.94% 13.42% 15.75% 18.29% 19.71% 17.67% 21.16%
Cash Return on Invested Capital (CROIC)
-1.86% -0.36% 1.07% 3.79% 3.86% 8.81% 6.26% 8.23% 8.09% 6.83%
Operating Return on Assets (OROA)
8.16% 7.78% 7.77% 7.87% 7.91% 9.40% 10.75% 11.91% 10.65% 12.94%
Return on Assets (ROA)
5.35% 4.98% 4.76% 4.87% 4.85% 6.17% 7.35% 8.14% 7.33% 9.12%
Return on Common Equity (ROCE)
6.17% 12.15% 6.32% 12.79% 13.31% 15.62% 9.25% 19.53% 17.49% 20.92%
Return on Equity Simple (ROE_SIMPLE)
12.31% 0.00% 0.00% 11.15% 11.05% 0.00% 13.15% 14.61% 15.83% 0.00%
Net Operating Profit after Tax (NOPAT)
208 200 211 211 217 259 307 336 299 363
NOPAT Margin
6.24% 5.81% 6.10% 5.95% 6.10% 6.99% 8.00% 8.60% 7.55% 8.83%
Net Nonoperating Expense Percent (NNEP)
0.73% 0.65% 1.02% 0.85% 0.96% 0.79% 0.82% 0.85% 0.65% 0.55%
Return On Investment Capital (ROIC_SIMPLE)
- 1.79% - - - 2.33% - - - 3.12%
Cost of Revenue to Revenue
50.28% 49.35% 50.56% 49.89% 50.10% 48.58% 47.94% 47.51% 48.25% 46.37%
SG&A Expenses to Revenue
36.08% 37.76% 36.31% 37.16% 37.05% 37.60% 37.35% 36.63% 37.36% 37.65%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
41.45% 43.07% 41.40% 42.21% 41.89% 42.48% 41.95% 41.33% 42.05% 42.15%
Earnings before Interest and Taxes (EBIT)
270 266 265 274 274 335 389 431 386 478
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
416 415 407 417 411 480 530 578 536 625
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.09 1.68 0.00 1.81 1.43 1.69 1.99 1.91 2.31 1.78
Price to Tangible Book Value (P/TBV)
3.22 4.95 0.00 5.11 4.03 4.68 5.34 4.87 5.79 4.33
Price to Revenue (P/Rev)
0.48 0.74 0.66 0.80 0.62 0.73 0.85 0.82 0.99 0.75
Price to Earnings (P/E)
8.61 14.74 13.03 15.92 12.84 14.44 15.24 13.25 14.89 10.36
Dividend Yield
0.92% 0.57% 0.63% 0.51% 0.64% 0.53% 0.44% 0.43% 0.35% 0.45%
Earnings Yield
11.61% 6.78% 7.68% 6.28% 7.79% 6.93% 6.56% 7.55% 6.72% 9.65%
Enterprise Value to Invested Capital (EV/IC)
1.05 1.36 1.80 1.44 1.23 1.38 1.54 1.52 1.75 1.45
Enterprise Value to Revenue (EV/Rev)
0.87 1.13 1.48 1.17 1.00 1.06 1.20 1.15 1.32 1.05
Enterprise Value to EBITDA (EV/EBITDA)
7.07 9.59 12.42 9.72 8.46 8.87 9.58 8.62 9.55 7.35
Enterprise Value to EBIT (EV/EBIT)
10.87 15.22 19.36 14.97 12.94 13.26 13.86 12.07 13.17 9.91
Enterprise Value to NOPAT (EV/NOPAT)
14.31 19.85 25.19 19.35 16.62 16.92 17.70 15.39 16.88 12.78
Enterprise Value to Operating Cash Flow (EV/OCF)
11.22 15.17 23.85 13.73 12.55 12.00 12.83 10.20 10.90 8.07
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 173.61 38.79 32.47 15.62 24.91 18.61 21.85 21.66
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.86 0.87 0.86 0.83 0.87 0.79 0.83 0.75 0.75 0.72
Long-Term Debt to Equity
0.85 0.86 0.84 0.81 0.85 0.77 0.81 0.73 0.75 0.72
Financial Leverage
0.70 0.76 0.80 0.82 0.85 0.82 0.83 0.77 0.79 0.74
Leverage Ratio
2.14 2.19 2.22 2.24 2.27 2.26 2.23 2.19 2.21 2.19
Compound Leverage Factor
1.85 1.82 1.79 1.84 1.83 1.89 1.93 1.94 1.95 2.01
Debt to Total Capital
46.31% 46.57% 46.20% 45.42% 46.50% 44.20% 45.35% 42.89% 42.95% 41.92%
Short-Term Debt to Total Capital
0.60% 0.73% 0.85% 0.99% 1.11% 1.14% 1.10% 1.11% 0.33% 0.34%
Long-Term Debt to Total Capital
45.71% 45.84% 45.34% 44.43% 45.39% 43.06% 44.24% 41.78% 42.62% 41.57%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.48% 0.44% 53.81% 0.41% 0.41% 0.48% 0.47% 0.62% 0.69% 0.83%
Common Equity to Total Capital
53.20% 52.99% 0.00% 54.17% 53.10% 55.32% 54.18% 56.49% 56.36% 57.25%
Debt to EBITDA
3.15 3.30 3.22 3.09 3.22 2.86 2.85 2.46 2.37 2.15
Net Debt to EBITDA
3.10 3.24 3.15 3.04 3.17 2.79 2.79 2.40 2.32 2.10
Long-Term Debt to EBITDA
3.11 3.25 3.16 3.02 3.14 2.79 2.78 2.40 2.35 2.13
Debt to NOPAT
6.37 6.84 6.53 6.14 6.32 5.46 5.26 4.40 4.19 3.74
Net Debt to NOPAT
6.28 6.70 6.39 6.05 6.22 5.33 5.15 4.28 4.10 3.64
Long-Term Debt to NOPAT
6.29 6.73 6.41 6.01 6.17 5.32 5.13 4.28 4.16 3.71
Altman Z-Score
1.61 2.52 1.84 1.99 1.81 2.59 2.17 2.21 2.42 2.82
Noncontrolling Interest Sharing Ratio
52.32% 1.30% 51.20% 1.16% 0.83% 0.84% 49.41% 0.92% 0.99% 1.15%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.27 1.33 1.37 1.29 1.38 1.40 1.38 1.28 1.39 1.27
Quick Ratio
1.02 1.11 1.15 1.07 1.16 1.17 1.16 1.06 1.15 1.04
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-786 -599 -470 -205 -193 333 19 143 26 -172
Operating Cash Flow to CapEx
136.56% 180.79% 172.30% 216.15% 80.83% 219.21% 190.09% 281.40% 134.30% 267.72%
Free Cash Flow to Firm to Interest Expense
-22.04 -13.65 -9.23 -4.20 -3.61 6.22 0.37 2.92 0.58 -4.33
Operating Cash Flow to Interest Expense
6.19 6.77 5.71 7.43 3.03 8.44 7.50 13.89 7.46 16.58
Operating Cash Flow Less CapEx to Interest Expense
1.66 3.03 2.40 3.99 -0.72 4.59 3.56 8.95 1.90 10.38
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
1.01 1.01 1.02 1.02 1.03 1.04 1.06 1.08 1.09 1.11
Accounts Receivable Turnover
7.22 7.12 7.17 7.01 6.78 6.71 6.77 7.05 6.93 7.17
Inventory Turnover
31.78 31.80 32.14 32.48 32.42 32.64 33.30 33.55 34.10 34.34
Fixed Asset Turnover
2.28 2.27 2.29 2.30 2.33 2.37 2.42 2.43 2.46 2.49
Accounts Payable Turnover
3.67 10.44 3.78 3.73 3.92 11.37 4.15 3.86 4.03 12.07
Days Sales Outstanding (DSO)
50.59 51.27 50.92 52.09 53.83 54.38 53.93 51.77 52.66 50.92
Days Inventory Outstanding (DIO)
11.49 11.48 11.35 11.24 11.26 11.18 10.96 10.88 10.70 10.63
Days Payable Outstanding (DPO)
99.41 34.96 96.62 97.96 93.17 32.11 87.90 94.46 90.62 30.24
Cash Conversion Cycle (CCC)
-37.34 27.79 -34.35 -34.63 -28.08 33.46 -23.01 -31.81 -27.26 31.30
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
10,931 11,087 11,147 11,158 11,342 11,012 11,435 11,351 11,615 11,548
Invested Capital Turnover
1.27 1.25 1.26 1.26 1.26 1.29 1.30 1.33 1.34 1.40
Increase / (Decrease) in Invested Capital
994 799 681 416 410 -75 288 194 273 535
Enterprise Value (EV)
11,449 15,111 20,068 16,085 13,961 15,208 17,620 17,243 20,287 16,687
Market Capitalization
6,373 9,961 8,922 11,015 8,685 10,362 12,441 12,377 15,278 11,836
Book Value per Share
$80.24 $82.91 $0.00 $86.73 $87.40 $90.08 $93.10 $96.90 $99.02 $101.06
Tangible Book Value per Share
$27.15 $28.16 ($55.38) $30.74 $31.02 $32.47 $34.65 $38.00 $39.58 $41.44
Total Capital
11,006 11,174 11,257 11,237 11,422 11,114 11,547 11,480 11,721 11,644
Total Debt
5,097 5,204 5,200 5,104 5,311 4,912 5,236 4,924 5,034 4,881
Total Long-Term Debt
5,031 5,122 5,104 4,993 5,185 4,786 5,109 4,796 4,996 4,841
Net Debt
5,023 5,101 5,090 5,025 5,230 4,793 5,124 4,795 4,928 4,755
Capital Expenditures (CapEx)
162 164 169 168 200 206 209 241 248 246
Debt-free, Cash-free Net Working Capital (DFCFNWC)
509 602 682 621 809 805 811 590 723 520
Debt-free Net Working Capital (DFNWC)
584 704 792 701 890 925 923 719 829 646
Net Working Capital (NWC)
517 623 696 589 763 798 796 591 791 606
Net Nonoperating Expense (NNE)
31 30 49 42 49 39 42 42 33 26
Net Nonoperating Obligations (NNO)
5,023 5,117 5,090 5,025 5,230 4,810 5,124 4,795 4,928 4,785
Total Depreciation and Amortization (D&A)
146 148 142 144 137 145 141 147 150 147
Debt-free, Cash-free Net Working Capital to Revenue
3.85% 4.49% 5.02% 4.50% 5.77% 5.64% 5.53% 3.93% 4.69% 3.29%
Debt-free Net Working Capital to Revenue
4.41% 5.26% 5.83% 5.08% 6.34% 6.47% 6.30% 4.79% 5.38% 4.08%
Net Working Capital to Revenue
3.91% 4.65% 5.13% 4.27% 5.44% 5.59% 5.43% 3.94% 5.13% 3.83%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$2.52 $2.44 $2.31 $2.44 $2.42 $3.18 $3.90 $4.32 $3.89 $5.05
Adjusted Weighted Average Basic Shares Outstanding
72.60M 73.12M 70.54M 70.07M 68.87M 69.32M 67.20M 66.88M 66.54M 66.55M
Adjusted Diluted Earnings per Share
$2.50 $2.42 $2.28 $2.42 $2.40 $3.13 $3.82 $4.26 $3.80 $4.94
Adjusted Weighted Average Diluted Shares Outstanding
73.06M 73.83M 71.49M 70.84M 69.62M 70.13M 68.48M 67.92M 68.11M 67.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
71.41M 70.67M 70.18M 69.39M 68.26M 67.22M 66.93M 66.71M 65.97M 65.00M
Normalized Net Operating Profit after Tax (NOPAT)
208 200 211 211 217 259 307 336 299 363
Normalized NOPAT Margin
6.24% 5.81% 6.10% 5.95% 6.10% 6.99% 8.00% 8.60% 7.55% 8.83%
Pre Tax Income Margin
7.02% 6.45% 6.17% 6.33% 6.19% 7.59% 8.74% 9.78% 8.62% 10.65%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
7.57 6.07 5.21 5.60 5.13 6.25 7.36 8.81 8.65 12.03
NOPAT to Interest Expense
5.84 4.56 4.15 4.32 4.07 4.83 5.82 6.88 6.70 9.15
EBIT Less CapEx to Interest Expense
3.04 2.32 1.89 2.16 1.38 2.39 3.41 3.88 3.10 5.84
NOPAT Less CapEx to Interest Expense
1.31 0.82 0.84 0.88 0.33 0.98 1.87 1.94 1.15 2.96
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
16.03% 17.10% 16.34% 16.01% 9.02% 8.28% 7.22% 5.70% 4.77% 4.03%
Augmented Payout Ratio
178.91% 143.88% 99.00% 86.34% 82.88% 84.37% 80.68% 66.43% 60.48% 61.70%

Frequently Asked Questions About Universal Health Services' Financials

When does Universal Health Services's financial year end?

According to the most recent income statement we have on file, Universal Health Services' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Universal Health Services' net income changed over the last 9 years?

Universal Health Services' net income appears to be on an upward trend, with a most recent value of $1.16 billion in 2024, rising from $750.70 million in 2015. The previous period was $719.31 million in 2023.

What is Universal Health Services's operating income?
Universal Health Services's total operating income in 2024 was $1.68 billion, based on the following breakdown:
  • Total Gross Profit: $8.31 billion
  • Total Operating Expenses: $6.63 billion
How has Universal Health Services revenue changed over the last 9 years?

Over the last 9 years, Universal Health Services' total revenue changed from $9.04 billion in 2015 to $15.83 billion in 2024, a change of 75.0%.

How much debt does Universal Health Services have?

Universal Health Services' total liabilities were at $7.71 billion at the end of 2024, a 0.8% decrease from 2023, and a 52.2% increase since 2015.

How much cash does Universal Health Services have?

In the past 9 years, Universal Health Services' cash and equivalents has ranged from $33.75 million in 2016 to $1.22 billion in 2020, and is currently $125.98 million as of their latest financial filing in 2024.

How has Universal Health Services' book value per share changed over the last 9 years?

Over the last 9 years, Universal Health Services' book value per share changed from 43.16 in 2015 to 101.06 in 2024, a change of 134.2%.



This page (NYSE:UHS) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners